31 Small molecules or synthetic compounds account for around 70% of APIs on the market today. Due to the considerable economic benefits of outsourcing API manufacturing, there has always been a substantial reliance on CDMOs for APIs. Outsourcing is anticipated to rise further in the next decades because of the increasing complexity of APIs, which are increasingly potent and need expert handling. As of March 31, 2024, approximately 25% of the combined total of 49 late phase (commercial, Phase III and post-Phase- III products) and 35% of the 100 early-phase products in our portfolio are APIs. We believe that this percentage of APIs in the product portfolio reflects our customers’ confidence in our quality and regulatory compliance. 15 of these 49 late phase products were transferred to our manufacturing facilities from another facility. Our scientific talent and laboratory infrastructure support diverse therapeutic areas such as oncology, immuno-oncology, CNS, autoimmune diseases, metabolic disorders, fibrosis, rare diseases, and more. The technical and R&D infrastructure capabilities resulted in us being awarded an early stage, complex and lengthy carbohydrate chemistry project with several chemical steps by an innovator pharmaceutical company. As a result of our process development efforts, we were able to reduce the cost by more than 70%, and we were also able to improve the product yield. Our diverse customer base includes global pharmaceutical companies and biotechnology companies, including 18 out of the top 25 pharmaceutical companies across the regulated markets of the US, the UK, EU and Japan. The number of customers we serviced among the top 25 pharmaceutical companies, doubled from 9 in the FY19 to 18 in FY24. We have made significant investment in our organizational transformational initiative, Sai Nxt to augment our talent, processes, and infrastructure. Our community investment includes making donations and contributions to various foundations involved in providing skill development and livelihood generation centre, conducting health camps, and providing education to underprivileged sections with a specific focus on women and girls. Our CSR spent in the reporting year was 0.2 million USD. Our Impact
RkJQdWJsaXNoZXIy MTIwMDc4NQ==